Background: Alcoholic liver cirrhosis is a common indication for liver transplantation. Recurrence of alcohol use was retrospectively analyzed after liver transplantation.
INTRODUCTION
Although alcoholic liver disease (ALD) as an indication for liver transplantation (OLT) is indisputable, it deserves special attention. Patients with ALD indicated for OLT are selected using strict criteria to minimize the risk of recurrent alcohol use. The number of patients diagnosed with ALD increases and long-term total abstinence is the basic prerequisite for inclusion into the waiting list for OLT. Despite the strict and comprehensive inclusion criteria, alcohol use recurs in 10-50% of patients, resulting in severe liver graft damage in 10% of cases [1] [2] [3] [4] [5] .
The definition of alcohol drinking after OLT is disputable. "Relapse" or "recidivism" is often published in literature [6, 7] . In studies of alcohol use after OLT, "relapse "is generally defined as any alcohol use. We have used to term "alcohol use (AU)" which is any intake of alcohol after OLT. Alcohol use and dependence are diagnosed for which are established diagnostic criteria [8] . Alcohol use can be identified using laboratory tests such as Aspartatetransaminase (AST): alanin-aminotransferase (ALT) ratio, GMT gamaglutamyl transferase (GMT), medium corpuscular volume (MCV) and triglyceride level determination. However, these tests are commonly biased by other posttransplantation factors. Thus, it is either the patient's acknowledgement or the finding of alcohol or its metabolites in his/her blood that provide unequivocal evidence of alcohol use. In our study, a structured-questionnaire method was used to detect alcohol use recurrence in patients after OLT.
The goal of this retrospective study was to evaluate the course of post-transplant treatment of liver transplant recipients in terms of alcohol use recurrence.
SUBJECTS
From October 1995 through February 2002, 246 patients with ALD were indicated for OLT in the transplant center at the Institute for Clinical and Experimental Medicine (IKEM) in Prague, Czech Republic. Of this number, 42 (17.1%) were diagnosed with ALD and 30 (6.4%) with liver cirrhosis of mixed etiology (for example hepatitis and use alcohol) and others), which were excluded from study. Only patients with at least one liver graft biopsy sample obtained at least one year after OLT were eligible for inclusion into the study. All patients gave their informed consent prior to their inclusion in the study. P.S.: This study was performed in accordance with the ethical standards laid down in the 1964 declaration of Helsinki.
METHODS
Any acknowledged alcohol consumption in the questionnaire alcohol use recurrence was regarded as alcohol use ( Table 1) . The main and only criterion for alcohol use was characterized as any alcohol intake indicating for alcohol use as well as this was also used as our definition. We prefer any intake as alcohol use because our country is leading in drinking habits as compared to other countries. This questionnaire was prepared by psychiatric with view to alcohol addiction and our hepatology teams.
All patients underwent psychological a psychiatric evaluation before OLT. Six month abstinence period is strictly keeping before OLT in majority of transplant centers. One justification of the period of abstinence before OLT has been to allow patients with acute alcoholic hepatitis the opportunity to recover with medical management. Up to now, patients with recent alcohol use have been precluded from OLT. But, we lack good data to determine whether some of these patients would benefit from OLT [9] . In our centre we have significantly required 6 months abstinence before OLT.
The following measures were evaluated as parameters: gammaglutamyl-tranferase (GMT), mean erythrocyte volume (MCV), triglycerides (TAG), and body mass index (BMI). Liver graft function was assessed using serum albumin level and prothrombin time. Liver graft biopsies were reevaluated semi quantitatively from the point of view of occurrence of liver steatosis, Mallory hyaline and fibrosis. The survival rates of patients and liver grafts in the above groups at 1, 3, and 5 years after the transplantation were compared using the Kaplan-Meier curve. Student's t-test, the 2 -test (Pearson) and Fischer's exact test were used for statistical analysis. Only first transplant procedures were included in the study.
RESULTS
Thirty-eight out of 42 patients (90%) completed the questionnaire ( Table 2) , four patients did not respond, and three patients died with unequivocally established alcohol use (acknowledgement, alcohol found in blood). Thirteen patients acknowledged alcohol use recurrence in the questionnaire.
No patient acknowledged daily alcohol consumption. Nine patients with acknowledged alcohol use and one patient declaring abstinence underwent psychological/psychiatric investigation. Eight patients acknowledged appetite for an alcoholic drink, all from the group with confirmed alcohol use. Patients who acknowledged alcohol use usually declared alcohol intake 4 and more times a month. The most common alcoholic beverage was beer. Three patients who died with unequivocally established alcohol use were included into the group which acknowledged alcohol consumption in the questionnaire. Among the 42 patients who underwent OLT for ALD, alcohol use was found in 16 (38%) patients (Table 3 ) In 4, alcohol use was accompanied by the development of liver graft dysfunction; of this number, 2 patients died of liver graft failure due to alcohol use recurrence. Another patient with substantial alcohol use refused haemodialysis therapy and died of renal failure. Twelve patients resumed alcohol use without detectable liver graft dysfunction. Substantial liver graft steatosis occurred in the acknowledged alcohol use group; moreover, it was only this group which showed occurrence of Mallory hyaline. The alcoholic origin of the liver graft steatosis in this group is supported by the lower incidence of risk factors such as obesity, diabetes, and HCV, by lower BMI and higher activity of GMT, MCV, and TAG. No difference was found in the incidence of liver fibrosis ( Table 4) . Three patients of the acknowledged alcohol use group were diagnosed to have acute alcoholic hepatitis (p<0.07; NS, 2 -test). Survival rates of patients and liver grafts are identical in our study as no patient transplanted for alcoholic liver cirrhosis was re-transplanted. The cumulative one-, three-, and five-year survival rates of patients with alcohol use after OLT were lower relative to abstaining patients (100%, 83%, and 74% vs 100%, respectively; p<0.05, Kaplan-Meier curve). Total survival rate of patients with ALD after OLT was higher compared to other etiologies, but the difference was not significant (93% vs 85%, NS, Table 5 ).
Treatment of recurrence of alcohol use after OLT was performed by standard psychiatric and psychological procedures. Four patients who were died to alcohol use after OLT denied psychiatric treatment.
DISCUSSION
Liver transplantation for ALD is a standard therapy for advanced liver cirrhosis. Alcohol use is a specific risk with all consequences including liver graft failure and death of the patient. Considering the potential consequences, any alcohol [11] . Due to the risk of alcohol use recurrence, the indication of ALD for OLT was to some extent controversial in the past. At the beginning of the transplantation program, this risk was connected only with reneged 6-months abstinence period [3, 12] . Gish et al. [13] have identified risk factors of alcohol use recurrence after OLT. They assume that nondocumented abstinence, repeated failure of abstinence and anti-alcoholic therapy, low social background and psychiatric disease are the most critical risk factors. In their data of 46 patients, the most serious risk factors for alcohol use appeared to be insufficient compliance with antialcoholic therapy and psychiatric disease preceding OLT. In such a case, the median time of recurrence was 2 to 3 years.
Selection of patients with this diagnosis for inclusion into the waiting list for OLT is subject to strict criteria in order to increase probability of total abstinence. The main criteria applied at IKEM are a detailed psychiatric-psychological examination, personal contacts with physicians and a documented 6-month abstinence period. In our department, patients with ALD stand an approximately 50% chance of being included into the waiting list for OLT compared to other etiologies [14] .
Despite the risk of alcohol use after OLT, the number of patients with this diagnosis indicated for OLT has been on the rise. In 1990, 25% of patients included in the European Register of Liver Transplantation had the above diagnosis. In 1996, the figure was as high as 40%. Between 1968 and 1995, 2480 liver transplant procedures for ALD were carried out [i.e., 12% of all liver transplant procedures]. In this study, alcohol use was detected in 28% of patients [5-60%] [1]. Other authors have reported alcohol use rates of 10-49% [1] [2] [3] 12] . Using a questionnaire before and after OLT, Osorio et al. [12] examined 43 patients with ALD. In their study, the despondence rate was 86%; of this number, 19% acknowledged alcohol use after OLT.
In earlier studies [15] , the survival rates of patients with ALD after OLT were lower than that of patients with other etiologies. Currently, a number of studies have shown that the survival rate of patients with this etiology is higher or equivalent to other etiologies [1] . In the study of Pageaux et al. [16] , the survival rate of patients with ALD did not differ from the rate with other etiologies. Bellamy et al. [9] showed no influence of alcohol use recurrence on liver graft damage or failure. On the other hand, they report a higher incidence of malignancies, especially of otolaryngological and bronchial/pulmonary origin, which correlates with the recipients' higher morbidity and mortality rates. These findings are related to the frequent incidence of chronic nicotinism in alcoholics. We have no neoplasm "de novo" in our population after OLT for ALD during 7 years. Our study has some limitations. The main limitation is a small group of tested subjects. The questionare that we have used has not been validated for the large population, thus our results could not be considered as generalize conclusion. However our method might be a suitable tool for alcohol use reccurence diagnosis in specific patients after liver transplantation. In addition, precize evaluation is mandatory for OLT patients, therefore our main criterium have been chosen as positive " any alcohol intake" to detected the alcohol use highest number of patients. General psychiatric diagnostic methods are often inconclusive in alcohol use transplant patients, because OLT pateints are the specific group. Because the liver candidate selection procedure as well as costeffectiveness evaluation of OLT treatment might be responsible for this specificity. Unfortunately, the analysis dealing with the comparison of selected diagnostic alcohol use methods has not been our aim.
Clinical analysis and repeated outpatient examinations may lead to a suspicion for alcohol use in patients after OLT. However, unequivocal evidence is provided by the patients' acknowledgement or by direct detection of alcohol in the patient's blood or body fluids.
Detection of alcohol use recurrence after OLT is difficult. Generally, 50% of patients with alcohol use recurrence are identified on their first visit, but moderate forms may remain concealed for long [17] . Apart from biochemical laboratory tests, which can yield false positive as well as false negative results, our study used the questionnaire [12] . Standard alcohol use markers such as GMT, MCV, or AST/ALT ratio may serve as inaccurate measures of alcohol use. They can be influenced by other factors such as obesity, immunosuppressive therapy, or hyperlipoproteinemia.
A Viennese group [18] considers carbohydrate-deficient transferrin [CDT] a reliable method for detecting posttransplant alcohol use with 92% sensitivity and 98% specificity. By contrast, Sorvajarvi et al. [19] did not confirm the reliability of CDT. Berlakovich et al. [10] used immunosuppressive [cyclosporin] levels as a measure of compliance with therapy.
A histopathological examination of the liver graft is another possibility of detecting alcohol-induced changes. Birds et al. [20] found changes [Mallory hyaline, steatosis, fibrosis] corresponding to toxic alcoholic damage in patients with acknowledged alcohol use group. Our study also revealed a significant difference in the incidence of Mallory hyaline and liver graft steatosis between the groups of patients with acknowledged alcohol use group and declared abstinence. The incidence of liver steatosis may indicate recent alcohol use as it is reported to subside after approximately two months of abstinence.
Sixteen patients of our group acknowledged alcohol use. The clinical suspicion of alcohol use correlated with the questionnaire-based findings in 9 cases. The questionnaire revealed 7 new patients with alcohol use. The severity of liver graft steatosis, Mallory hyaline and laboratory and additional examinations correlated in patients with acknowledged alcohol use. A suspicion for alcohol use was also raised in 4 patients with a higher incidence of liver steatosis who did not respond to the questionnaire. In our study we had used a questionnaire with respect to our national population and Czech habits of alcohol drinking can be probably different in contrast to western world. We suppose that it may have great influence to results of our study.
CONCLUSION
Patients after liver transplantation for alcoholic liver cirrhosis with alcohol use show lower survival rates compared to those of patients with declared abstinence. Alcohol use after OLT may be fatal. Its incidence in our series corresponds to findings in the relevant literature. 
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